Interestingly, several gene expression changes in the ERα-positive cell lines MCF7 and T-47D adapting to PDSs were significantly associated with clinical properties of the original breast cancers, whereas similar analyses using MDA-MB-231 cells did not produce any statistically significant associations. The gene discussed is ESR1; the disease is breast carcinoma.